Secondary neurological sequelae resulting from acute lithium poisoning;Sequelles neurologiques secondaires a une intoxication aigue au lithium

Canadian Journal of Psychiatry

Volumn 44, Issue 7, 1999, Pages 671-679

  Roy, Mario ^a   Stip, Emmanuel ^a   Black, Deborah N ^a,b   Lew, Vivianne ^a   Langlois, Robert ^a  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Antipsychotics; Ataxia; Cerebellum; Lithium; Neurological side effects; Toxicity

Indexed keywords

ALCOHOL; AMINOPHYLLINE; AMPICILLIN; BENZATROPINE MESILATE; BENZODIAZEPINE DERIVATIVE; BIPERIDEN; CHLORPROMAZINE; CLORAZEPATE; COTRIMOXAZOLE; DIAZEPAM; DIPHENHYDRAMINE; FLUPHENAZINE; FLUPHENAZINE DECANOATE; FLUVOXAMINE; HALOPERIDOL; HYDRALAZINE; LEVOMEPROMAZINE; LITHIUM; MEPROBAMATE; NEUROLEPTIC AGENT; NORTRIPTYLINE; PERPHENAZINE; PIPERACILLIN; PROCYCLIDINE; PROPANOL; SALICYLIC ACID DERIVATIVE; TETRACYCLINE; TIOTIXENE; UNINDEXED DRUG; VERAPAMIL; NEUROTOXIN;

ARTICLE; CEREBELLUM DISEASE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DRUG INTOXICATION; DRUG POTENTIATION; HUMAN; LITHIUM BLOOD LEVEL; MEDICAL LITERATURE; MENTAL DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; RISK FACTOR; BRAIN; BRAIN DISEASE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; REVIEW;

ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN DISEASES; HUMANS; LITHIUM; NEUROTOXINS; RISK FACTORS;

EID: 0033191192     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379904400704     Document Type: Article

References (77)

1. Schou M. Forty years of lithium treatment. Arch Gen Psychiatry 1997;54:9-13.
2. Agulnik, PJ, Dimascio A, Moore P. Acute brain syndrome associated with lithium therapy. Am J Psychiatry 1972;129:5.
3. Schou M, Amdisen A, Trap-Jensen J. Lithium poisoning. Am J Psychiatry 1968;125:520-7.
4. Sansone ME, Ziegler DK. Lithium toxicity: a review of neurologic complications. Clin Neuropharmacol 1985;8:242-8.
5. Sheean GL. Lithium neurotoxicity. Clin Exp Neurol 1991;28:112-27.
6. Kores B, Lader MH. Irreversible lithium neurotoxicity: an overview. Clin Neuropharmacology. 1997;20(4):283-99.
7. Adityanjee. The syndrome of irreversible lithium-effectuated neurotoxicity (SILENT). Pharmacopsychiatry 1989;22:81-3.
8. Lecamwasam D, Synek B, Moyles K, Ghose K. Chronic lithium neurotoxicity presenting as Parkinson's disease. Int Clin Psychopharmacol 1994;9:127-9.
9. Cohen WJ, Cohen NH. Lithium carbonate, haloperidol and irreversible brain damage. JAMA 1974;230:1283-7.
10. Hansen HE, Amdisen A. Lithium intoxication. Q J Med New Series XLVII 1978;186:123-44.
11. Johnson GFS. Lithium neurotoxicity. Aust NZJ Psychiatry 1976;10:33-8.
12. Uchigata M, Tanabeh H, Hasue I, Kurihara M. Peripheral neuropathy due to lithium intoxication. Ann Neurol 1981;9:414.
13. Nagaraja D, Taly AB, Sahu RN, Channabasavanna SM, Narayanan HS. Permanent neurological sequelae due to lithium toxicity. Clin Neurol Neurosurg 1987:89-1:31-4.
14. Coppeto JR, Monteiro LR, Lessell S, Bear L, Maldonado MM. Downbeat nystagmus, long term therapy with moderate-dose lithiu carbonate. Arch Neurol 1983;40:754-55.
15. Halmagyi MG, Rudge P, Gresty MA, Sanders MD. Downbeating nystagmus: a review of 62 cases. Arch Neurol 1983;40:777-84.
16. Corbett JJ, Jacobson DM, Thompson HS, Hart MN, Albert DW. Downbeating nystagmus and other ocular motor defects caused by lithium toxicity. Neurology 1989;39:481-7.
17. Hartizsch von B, Hoenich NA, Leigh RJ, Wilkinson R, Frost TH, Weddel et autres. Permanent neurological sequelae despite haemodialysis for lithium intoxication. BMJ 1972;4:757-9.
18. Habib M, Khalil R, Le Pensec-Bertrand D, Ali-Cherif A, Bongrand MC, Crevat A. Syndrome neuroleptique persistant après traitement par les sels de lithium. Rev Neurol (Paris) 1986;142:61-4.
19. Naramato A, Koizumin N, Itoh N, Shigematsu H. An autopsy case of cerebellar degeneration following lithium intoxication with neuroleptic malignant syndrome. Acta Pathol J 1993;43:55-8.
20. Schneider JA, Mirra SS. Neuropathologic correlates of persistent neurologic deficit in lithium intoxication. Ann Neurol 1994;36:928-31.
21. Juul-Jensen P, Schou M. Permanent brain damage after lithium intoxication. BMJ 1973;4:673.
22. Julien J, Vallat JM, Lagueny A. Myopathy and cerebellar syndrome during acute poisoning with lithium carbonate. Muscle Nerve 1979;2:240.
23. Warick LH. Lithium poisoning, report of a case with neurologic, cardiac and hepatic sequelae. West J Med 1979;130:259-63.
24. Unger J, Decaux G, L'Hermite M. Rhabdomyolysis, acute renal failure, endocrine alterations and neurological sequelae in a case of lithium self poisoning. Acta Clin Belg 1982;37:216-23.
25. Apte S, Langston W. Permanent neurological deficits due to lithium toxicity. Ann Neurol 1983;13:453-5.
26. Bejar J. Cerebellar degeneration due to acute lithium toxicity. Clin Neuropharmacol 1985;8:379-381.
27. Servant D, Gaudet Y, Danel T, Goudemand M, Petit H. Syndrome cérébelleux durable après traitement par les sels de lithium. Presse Med 1987;16:312.
28. Roy M, Stip E, Black D, Lew V, Langlois R. Dégénérescence cérébelleuse secondaire à une intoxication aiguě au lithium. Rev Neurol (Paris) 1998;154:546-8.
29. Favarel-Garrigues B, Favarel-Garrigues JC, Bourgeois M. Deux cas d'intoxication grave par le carbonate de lithium. Ann méd psychol 1972;130:253-7.
30. Thomas CJ. Brain damage with lithium, haloperidol. Br J Psychiatry 1979;134:552.
31. Spring G, Frankel M. New data on lithium and haloperidol incompatibility. Am J Psychiatry 1981;138:818-21.
32. Bond W, Carvalho M, Foulks E. Persistent dysarthria with apraxia associated with a combination of lithium carbonate and haloperidol. J Clin Psychiatry 1982;43:256-7.
33. Singh SV. Lithium carbonate/fluphenazine decanoate producing irreversible brain damage. Lancet 1982;43:256-57.
34. Donaldson I, Cuningham J. Persisting neurologic sequelae of lithium carbonate therapy. Arch Neurol 1983;40:747-51.
35. Green JB. Permanent neurological deficits resulting from lithium toxicity. Ann Neurol 1984;15:111.
36. Jacome DE. Cerebellar syndrome in lithium poisoning. J Neurol Neurosurg Psychiatr 1987;50:1722-4.
37. Kiejna A, Krakiewicz A. Neurologic complications in patients treated with lithium. Psychiatr J Univ Ottawa 1988;13:164-6.
38. Modestin J, Foglia A. Lithiumintoxikation mit Persistierenden Neurologischen Storungen. Schweiz Med Wschr 1988;118:173-6.
39. Pelletier J, Habib M, Pelissier JF, Crevat A, Khalil R. Séquelles neurologiques de l'association neuroleptiques-lithium : rôle de l'hyperthermie. Rev Med Int 1991;12:187-91.
40. Goldwater L, Pollock M. Neurological sequelae after lithium intoxication. NZ Med J 1976;84:356-8.
41. Newman PK, Saunters M. Lithium neurotoxicity. Postgrad Med J 1979;55:701-3.
42. Pringuey D, Yzombard G, Charbit JJ, Portugal H, Saingra S, Frayssinet R, et autres. Lithium kinetics during hemodialysis in a patient with lithium poisoning. Am J Psychiatry 1981;138:249-52.
43. Manor E. A case of reversible tachy-bradycardia syndrome and permanent neurological sequelae in lithium intoxication. Arch Toxicol 1983;suppl 6:384-5.
44. Lippmann S, Arnold D, Taylor J, Manshadi M. Lithium carbonate toxicity induced cerebellar injury. Arch Neurol 1985;42:515.
45. Tesio L, Porta GL, Messa E. Cerebellar syndrome in lithium poisoning: a case of partial recovery. J Neurol Neurosurg Psychiatr 1987;50:235.
46. Verdoux H, Bourgeois ML. A case of lithium neurotoxicity with irreversible cerebellar syndrome. J Nerv Ment Dis 1990;178:761-2.
47. Goddard J, Bloom SR. Lithium intoxication. BMJ 1991;302:1267-9.
48. Swartz CM, Jones P. Hyperlithemia correction and persistent delirium. J Clin Pharmacol 1994;34:865-70.
49. Schou M. Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 1984;70:594-602.
50. Simard M, Gumbiner B, Lee A, Lewis H, Normand D. Lithium carbonate intoxication. Arch Int Med 1989;149:36-49.
51. Strayhorn JM, Nash JL. Severe neurotoxicity despite therapeutic serum lithium levels. Dis Nerv Syst 1977;38:107-11.
52. Solomon K, Vickers R. Dysarthria resulting from lithium carbonate. JAMA 1975;231:280.
53. Baastrup P, Hollnagel P, Sorensen R, Schou M. Adverse reactions in treatment with lithium carbonate and haloperidol. JAMA 1976;236:2645-6.
54. Shopsin B, Small JG, Kellams JJ, Milstein V, Moore JE. Combining lithium and neuroleptics. Am J Psychiatry 1976;133:980-1.
55. Rudorfer M, Raichman J. Questions about combined lithium and haloperidol treatment. Am J Psychiatry 1982;139:537.
56. Adityanjee. Neuroleptic malignant syndrome or lithium neurotoxicity. Br J Psychiatry 1987;150:568-9.
57. Okusa MD, Crystal LJ. Clinical manifestations and management of acute lithium intoxication. Am J Med 1994;97:383-9.
58. Unger J, Decaux G. Syndrome cérébelleux durable après traitement par les sels de lithium. Presse Med 1987;16:1546.
59. Verdoux H, Bourgeois M. Séquelles neurologiques irréversibles induites par le lithium. L'Encéphale 1991;17:221-4.
60. West AP, Meltzer HY. Paradoxical lithium neurotoxicity: a report of five cases and a hypothesis about risk for neurotoxicity. Am J Psychiatry 1979;136:963-6.
61. Manji HK, Potter WZ, Lenox RH. Signal transduction pathways: molecular targets for lithium's actions. Arch Gen Psychiatry 1995;52:531-543.
62. Sparapani M, Virgili M, Bardi G, Tregnano M, Monti B, Bentivogli M, Contestabile A. Ornithine decarboxylase activity during development of cerebellar granule neurons. J Neurochem 1998;71(5):1898-904.
63. Nonaka S, Hough CJ, Chuang DM. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-asparate receptor-mediated calcium influx. Proc Natl Acad Sci USA 1998;95(5):2642-7.
64. Jakobsen SN, Wiborg O. Selective effects of lithium-term lithium and carbamazepine administration on G-protein subunit expression in rat brain. Brain Res 1998;780(1):46-55.
65. Schou M. Hyperlithemia correction: an untraditional view. J Clin Psychiatry 1996;57:42.
66. Calabrese J, Woyshville MJ. A medication algorithm for treatment of bipolar rapid cycling? J Clin Psychiatry 1996;56(Suppl 3):11S-18S.
67. Botez MI. Le cervelet: comportement moteur et non moteur, neuropsychologie clinique et neurologie du comportement Les Presses de l'Université de Montréal, Masson, chap. XVII:318-37;1996.
68. Emilien G, Maloteaux JM. Lithium neurotoxicity at low therapeutic doses. Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports. Acta Neurol Belg 1996;96(4):281-93.
69. Moncrief J. Lithium revisited. A re-examination of the placebo-controlled trials prophylaxis in manic-depresive disorder. Br J Psychiatry 1995;167:569-74.
70. Moncrieff J. Forty years of lithium treatment. Arch Gen Psychiatry 1998;55:92-3.
71. Stip E, Daoust L. Valproate in the treatment of mood disorder due to multiple sclerosis. Can J Psychiatry 1995;40:219-22.
72. Maj M, Pirozzi R, Magliano L, Bartoli L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry 1998;155(1):30-5.
73. Silverstone T, McPherson H, Hunt N, Roman S. How effective is lithium in the prevention of relapse in bipolar disorder? A prospective naturalistic follow-up study. Aust N Z J Psychiatry 1998;32(1):61-6.
74. Grof P. Has the effectiveness of lithium changed? Impact of the variaty of lithium's effect Neuropsychopharamacology 1998;19(3):133-8.
75. Schou M. Has the time come to abandon prophylactic lithium treatment? A review for clinicians. Pharmacopsychiatry 1998;31(6):210-5.
76. Greil W, Kleindienst N, Erazo N, Muller-Oerlinghausen B. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 1998;18(6):455-60.
77. Vestergaard P, Wentzer Licht R, Brodersen A, Rassmussen NA, Christensen H, Arngrim T, et autres. Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels. Acta Psychiatr Scand 1998;98(4):310-305.